Of the 106 peptide and nanobody drug conjugates in active development, roughly 63% are still preclinical, which places many of the decisions that shape manufacturability in the design ...
AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies. For IND-enabling programs, conjugation process development ...
Antibodies are widely employed in the quantification of antigens in complex biological samples. Using techniques such as Western blotting, ELISA, and immunohistochemistry researchers are able to ...
A new wave of antibody-targeted anticancer therapies is showing great clinical promise, with the potential to transform cancer treatment. These antibody-drug conjugates (ADCs) are multicomponent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results